Strasbourg, France

Norbert B Ghyselinck


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Norbert B. Ghyselinck: Innovator in Genetic Research

Introduction

Norbert B. Ghyselinck, based in Strasbourg, France, is a prominent inventor known for his contributions to the field of genetic research. With a total of two patents to his name, Ghyselinck has developed innovative methods that pave the way for new treatments and applications in medicine and biotechnology.

Latest Patents

Ghyselinck's latest patents reflect his groundbreaking work in DNA manipulation and treatment of neurological diseases. The first patent, titled "Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof," focuses on a method for the stable inversion of a DNA fragment using recombinase-mediated rearrangements. This method utilizes two sets of incompatible site-specific recombinase targeting sites to facilitate the stable inversion of a DNA fragment, providing valuable tools for genetic engineering and transgenic cell development.

The second patent, "Use of ligands for treatment of diseases responsive to retinoids," addresses the treatment of neurological diseases by administering agents that interact with retinoid receptors associated with these disorders. This invention also encompasses methods for modulating dopamine receptor synthesis and features a transgenic animal model that aids in the study of receptor interactions and neurological functions.

Career Highlights

Throughout his career, Norbert B. Ghyselinck has worked with notable institutions such as GIE-CERBN and the Centre Européen de Recherche en Biologie et en Médecine (GIE). His experience in these organizations has significantly contributed to advancements in genetic research and therapy.

Collaborations

Ghyselinck has collaborated with renowned colleagues, including Pierre H. Chambon and Frank Schnutgen. These partnerships have fostered innovation and expansion within the scientific community, leading to significant advancements in the understanding of genetic mechanisms and their implications in disease treatment.

Conclusion

Norbert B. Ghyselinck's contributions to the fields of genetics and biotechnology demonstrate his commitment to advancing scientific knowledge and therapeutic options. Through his innovative patents and collaborative efforts, he continues to make a significant impact in the world of research and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…